Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Sep. 30, 2014 | Nov. 12, 2014 | |
Document And Entity Information | ' | ' |
Entity Registrant Name | 'MV Portfolios, Inc. | ' |
Entity Central Index Key | '0001363573 | ' |
Document Type | '10-Q | ' |
Document Period End Date | 30-Sep-14 | ' |
Amendment Flag | 'false | ' |
Current Fiscal Year End Date | '--06-30 | ' |
Is Entity a Well-known Seasoned Issuer? | 'No | ' |
Is Entity a Voluntary Filer? | 'No | ' |
Is Entity's Reporting Status Current? | 'Yes | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Common Stock, Shares Outstanding | ' | 21,202,323 |
Document Fiscal Period Focus | 'Q1 | ' |
Document Fiscal Year Focus | '2015 | ' |
CONSOLIDATED_BALANCE_SHEETS_Un
CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) | Sep. 30, 2014 | Jun. 30, 2014 | ||
Current assets: | ' | ' | ||
Cash | $554,503 | $1,468,401 | ||
Prepaid expenses | 166,667 | 280,880 | ||
Assets held for sale - from discontinued operations | 3,167 | 3,608 | ||
Deferred financing costs | ' | 689,556 | ||
Total current assets | 724,337 | 2,442,445 | ||
Mining rights | 450,000 | ' | ||
Total assets | 1,174,337 | 2,442,445 | ||
Current liabilities: | ' | ' | ||
Accounts payable and accrued expenses | 534,688 | 640,364 | ||
Derivative liabilities | 2,283,712 | [1] | 2,365,315 | [2] |
Convertible notes | ' | 3,959,995 | ||
Total current liabilities | 2,818,400 | 6,965,674 | ||
Convertible notes, net of unamortized discounts of $211,543 | ' | 113,457 | ||
Total liabilities | 2,818,400 | 7,079,131 | ||
Stockholders' deficit: | ' | ' | ||
Common stock, par value $0.001 per share, 300,000,000 shares authorized; 11,026,013 shares issued and outstanding | 760,436 | 173,486 | ||
Additional paid-in capital | 13,631,577 | -238,674 | ||
Accumulated deficit | -16,055,406 | -4,579,498 | ||
Total stockholders' deficit | -1,644,063 | -4,636,686 | ||
Total liabilities and stockholders' deficit | 1,174,337 | 2,442,445 | ||
Series A Preferred [Member] | ' | ' | ||
Stockholders' deficit: | ' | ' | ||
Convertible preferred stock: Series A, par value $0.001 per share; 50,000,000 shares authorized; 8,000,000 shares issued and outstanding Series B, par value $0.001 per share; 3,592,240 shares authorized; 3,592,238 and no shares issued and outstanding; Series C, par value $0.001 per share; 50,000,000 and 7,717,170 shares issued and outstanding; Series D, par value $0.001 per share; 50,000,000 shares authorized; 20,000 and no shares issued and outstanding | ' | 8,000 | ||
Series B Preferred Stock [Member] | ' | ' | ||
Stockholders' deficit: | ' | ' | ||
Convertible preferred stock: Series A, par value $0.001 per share; 50,000,000 shares authorized; 8,000,000 shares issued and outstanding Series B, par value $0.001 per share; 3,592,240 shares authorized; 3,592,238 and no shares issued and outstanding; Series C, par value $0.001 per share; 50,000,000 and 7,717,170 shares issued and outstanding; Series D, par value $0.001 per share; 50,000,000 shares authorized; 20,000 and no shares issued and outstanding | 8,000 | 3,593 | ||
Series C Preferred Stock [Member] | ' | ' | ||
Stockholders' deficit: | ' | ' | ||
Convertible preferred stock: Series A, par value $0.001 per share; 50,000,000 shares authorized; 8,000,000 shares issued and outstanding Series B, par value $0.001 per share; 3,592,240 shares authorized; 3,592,238 and no shares issued and outstanding; Series C, par value $0.001 per share; 50,000,000 and 7,717,170 shares issued and outstanding; Series D, par value $0.001 per share; 50,000,000 shares authorized; 20,000 and no shares issued and outstanding | ' | 7,717 | ||
Series D Preferred [Member] | ' | ' | ||
Stockholders' deficit: | ' | ' | ||
Convertible preferred stock: Series A, par value $0.001 per share; 50,000,000 shares authorized; 8,000,000 shares issued and outstanding Series B, par value $0.001 per share; 3,592,240 shares authorized; 3,592,238 and no shares issued and outstanding; Series C, par value $0.001 per share; 50,000,000 and 7,717,170 shares issued and outstanding; Series D, par value $0.001 per share; 50,000,000 shares authorized; 20,000 and no shares issued and outstanding | ' | $20 | ||
[1] | MV Portfolios, Inc. and Subsidiaries | |||
[2] | MV Patents, LLC |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Sep. 30, 2014 | Jun. 30, 2014 |
Convertible notes, net of unamortized discounts | $0 | $211,543 |
Preferred stock, par value | $0.00 | $0.00 |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 300,000,000 | 300,000,000 |
Common stock, shares issued | 16,895,518 | 11,026,013 |
Common stock, shares outstanding | 16,895,518 | 11,026,013 |
Series A Preferred [Member] | ' | ' |
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, shares issued | 8,000,000 | 8,000,000 |
Preferred stock, shares outstanding | 8,000,000 | 8,000,000 |
Series B Preferred Stock [Member] | ' | ' |
Preferred stock, shares authorized | 3,592,240 | 3,592,240 |
Preferred stock, shares issued | 3,592,238 | 0 |
Preferred stock, shares outstanding | 3,592,238 | 0 |
Series C Preferred Stock [Member] | ' | ' |
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, shares issued | 7,717,170 | 0 |
Preferred stock, shares outstanding | 7,717,170 | 0 |
Series D Preferred [Member] | ' | ' |
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, shares issued | 20,000 | 0 |
Preferred stock, shares outstanding | 20,000 | 0 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Operating Expenses: | ' | ' |
General and administrative | $6,927,127 | $150,727 |
Loss from operations | 6,927,127 | 150,727 |
Other income (expenses): | ' | ' |
Interest expense | -4,629,943 | -3,399 |
Gain on change in fair value of derivative liabilities | 81,603 | ' |
Total other expenses, net | -4,548,340 | -3,399 |
Loss from continuing operations | -11,475,467 | -154,126 |
Loss from discontinued operations | -441 | ' |
Net loss | ($11,475,908) | ($154,126) |
Basic and diluted net loss per share: | ' | ' |
Loss from continuing operations per share | ($0.92) | ' |
Loss from discontinued operations per share | $0 | ' |
Net loss per share | ($0.92) | ' |
Weighted average number of common shares outstanding - basic and diluted | 12,478,079 | ' |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Cash flows from operating activities: | ' | ' |
Net loss | ($11,475,908) | ($154,126) |
Adjustments to reconcile net loss to net cash flows used in operating activities: | ' | ' |
Depreciation | 441 | ' |
Amortization of debt discounts and deferred financing | 4,561,099 | ' |
Gain on change in fair value of derivative liabilities | -81,603 | ' |
Options expense | 2,669,673 | ' |
Common stock issued for services | 2,800,000 | ' |
Series D preferred stock issued for services | 40,000 | ' |
Loss on common stock issued for liabilities | 229,850 | ' |
Loss on Series B preferred stock issued for liabilities | 220,470 | ' |
Changes in operating assets and liabilities: | ' | ' |
Prepaid expenses | 114,213 | ' |
Accounts payable and accrued expenses | 307,867 | 41,054 |
Accrued salaries, member | ' | 45,275 |
Other liabilities | ' | 50,000 |
Net cash used in operating activities | -613,898 | -17,797 |
Cash flows from financing activities: | ' | ' |
Repayment of convertible notes | 300,000 | ' |
Proceeds from participation notes | ' | 20,000 |
Net cash (used) provided by financing activities | -300,000 | 20,000 |
Net increase (decrease) in cash | -913,898 | 2,203 |
Cash, beginning of period | 1,468,401 | 2,523 |
Cash, end of period | 554,503 | 4,726 |
Supplemental disclosures of cash flow information: | ' | ' |
Interest paid | 15,000 | ' |
Income taxes paid | ' | ' |
Non-cash investing and financing activities: | ' | ' |
Beneficial conversion feature | 3,660,000 | ' |
Series B preferred stock issued for liabilities | 79,530 | ' |
Conversion of convertible notes to Series C preferred stock | 3,858,578 | ' |
Conversion of convertible notes to Series B preferred stock | 351,271 | ' |
Common stock issued to related party for mining rights | 450,000 | ' |
Common stock issued for liabilities | 109,159 | ' |
Common stock issued for exchange of warrants | $400,000 | ' |
CONSOLIDATED_STATEMENTS_OF_CHA
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) (USD $) | Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
Beginning Balance, Amount at Jun. 30, 2014 | $8,000 | $173,486 | ($238,674) | ($4,579,498) | ($4,636,686) |
Beginning Balance, Shares at Jun. 30, 2014 | 8,000,000 | 11,026,013 | ' | ' | ' |
Common stock issued to related party for mining rights, shares | ' | 300,000 | ' | ' | ' |
Common stock issued to related party for mining rights, value | ' | 30,000 | 420,000 | ' | 450,000 |
Common stock issued for liabilities, shares | ' | 169,505 | ' | ' | ' |
Common stock issued for liabilities, value | ' | 16,950 | 322,059 | ' | 339,009 |
Common stock issued for services, shares | ' | 1,400,000 | ' | ' | ' |
Common stock issued for services, value | ' | 140,000 | 2,660,000 | ' | 2,800,000 |
Common stock issued for exchange of warrants, shares | ' | 4,000,000 | ' | ' | ' |
Common stock issued for exchange of warrants, value | ' | 400,000 | -400,000 | ' | ' |
Series B preferred stock issued for liabilities, shares | 79,530 | ' | ' | ' | ' |
Series B preferred stock issued for liabilities, value | 80 | ' | 299,920 | ' | 300,000 |
Conversion of notes to Series B preferred stock, shares | 3,512,710 | ' | ' | ' | ' |
Conversion of notes to Series B preferred stock, value | 3,513 | ' | 347,758 | ' | 351,271 |
Conversion of notes to Series C preferred stock, shares | 7,717,170 | ' | ' | ' | ' |
Conversion of notes to Series C preferred stock, value | 7,717 | ' | 3,850,861 | ' | 3,858,578 |
Series D preferred stock issued for services, shares | 20,000 | ' | ' | ' | ' |
Series D preferred stock issued for services, value | 20 | ' | 39,980 | ' | 40,000 |
Beneficial conversion feature | ' | ' | 3,660,000 | ' | 3,660,000 |
Options expense | ' | ' | 2,669,673 | ' | 2,669,673 |
Net loss | ' | ' | ' | -11,475,908 | -11,475,908 |
Ending Balance, Amount at Sep. 30, 2014 | $19,330 | $760,436 | $13,631,577 | ($16,055,406) | ($1,644,063) |
Ending Balance, Shares at Sep. 30, 2014 | 19,329,410 | 16,895,518 | ' | ' | ' |
Interim_Financial_Statements
Interim Financial Statements | 3 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Note 1 - Interim Financial Statements | ' |
The unaudited consolidated financial statements of MV Portfolios, Inc. and Subsidiaries (collectively the “Company”) as of September 30, 2014 and for the three month periods ended September 30, 2014 and 2013 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. | |
The consolidated balance sheet of the Company at June 30, 2014 has been derived from the audited financial statements at that date, but does not include all of the information and notes required by accounting principles generally accepted in the United States for complete financial statements. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected as required by the SEC. Such adjustments are of a normal, recurring nature. It is suggested that these unaudited consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended June 30, 2014. The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period. |
General_Organization_and_Busin
General Organization and Business | 3 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Note 2 - General Organization and Business | ' |
MV Portfolios, Inc. and subsidiaries (collectively the “Company”) is a Nevada corporation. The Company was an exploration stage mining company with a focus on the identification, acquisition and development of rare and precious metals mining properties in the Americas. On February 7, 2014, the Company entered into a securities exchange agreement (the “Securities Exchange”) with MVP Portfolio, LLC (“MVP Portfolio”), a Florida limited liability company, MV Patents, LLC (“MV Patents”), a Florida limited liability company and majority member of MVP Portfolio, and other members of MVP Portfolio (all such members collectively, the “Members”). Pursuant to the Securities Exchange, the Members sold all of their membership interests in MVP Portfolio to the Company in exchange for an aggregate of 9,385,000 shares of common stock, $0.10 par value per share, after taking into account the 1 for 100 reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock. Following the Securities Exchange, the Company assumed the additional line of business of MVP Portfolio. | |
The Securities Exchange was consummated in anticipation of a 1 for 100 Reverse Split. As the share exchange is dependent upon the Reverse Split, all share and per share amounts herein have been retroactively restated to reflect the 1 for 100 Reverse Split as if it has been effected during all periods presented. | |
MV Patents, formed on July 11, 2011, has limited operations. MVP Portfolio was formed on July 26, 2013 as a wholly owned subsidiary of MV Patents. On August 30, 2013, MV Patents transferred a portion of its patents without recourse to MVP Portfolio. Pursuant to the Securities Exchange on February 7, 2014, MVP Portfolio ceased to be a subsidiary of MV Patents and became a wholly owned subsidiary of the Company. MV Patents is deemed to be the predecessor entity to MVP Portfolio. | |
On March 6, 2014, MVP Portfolio changed its form of organization to a Florida corporation from a Florida limited liability company, and changed its name to Visual Real Estate, Inc. (“VRE”). VRE has historically maintained a June 30 fiscal year, through MV Patents, the predecessor business to MVP Portfolio. | |
VRE has not commenced its planned principal operations, the business of patent licensing and assertion of rights under patents against parties believed to be selling goods or services that rely upon VRE’s patented technology. VRE owns a patent portfolio it refers to as “Video Drive-by” and online mapping, which has previously been used by its predecessors and licensees commercially. VRE currently owns a patent portfolio consisting of eight (8) issued and sixteen (16) pending patents. The patents disclose systems and methods for providing video drive-by data to enable a street level view of a neighborhood surrounding a geographic location. The systems include, generally, a video and data server farm incorporating at least one (1) video storage server that stores video image files containing video drive-by data corresponding to a geographic location, a data base server that processes a data query received from a user over the internet and an image processing server. VRE’s activities since inception have consisted principally of acquiring additional technology patents and raising capital. | |
Subsequent to the Securities Exchange, the Company changed its fiscal year end to June 30, which is VRE’s year end. |
Going_Concern
Going Concern | 3 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Note 3 - Going Concern | ' |
The Company is engaged in limited operations. The ongoing business plan of the Company is to assert its intellectual property rights to monetize its patents through net recoveries. Net recoveries relate to monetary payments received by the Company in respect to its patents through judgments, settlements, royalty agreements, or other disposition of the patents or cash proceeds of any equity actually received as consideration for any such disposition, including those received in connection with litigation. | |
The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. As shown in the accompanying consolidated financial statements, the Company has incurred losses for all periods presented, as the ongoing business has not yet commenced. The Company has not established an ongoing source of revenues and has funded activities to date primarily from convertible notes offerings. In addition, the Company had a working capital deficit as of September 30, 2014. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. | |
The Company is subject to a number of risks including, but not limited to, the need to obtain adequate funding and possible risk of failure to monetize its patents. If the Company does not successfully monetize its patents, it will be unable to generate revenues or achieve profitability. | |
Management’s plan with respect to funding the ongoing operations is to secure equity financing through access to U.S. capital markets as a registrant of the U.S. Securities and Exchange Commission. | |
While the Company believes it will be successful in obtaining the necessary financing to (i) fund its operations, (ii) monetize its patents and meet revenue projections and (iii) manage costs, it does not currently have any financing plans in place and there are no assurances that such additional funding will be achieved and that it will succeed in its future operations. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts of liabilities that might be necessary should the Company be unable to continue as a going concern. Operating results for the three month period ended September 30, 2014 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2015. |
Discontinued_Operations
Discontinued Operations | 3 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Discontinued Operations and Disposal Groups [Abstract] | ' | ||||||||
Note 4 - Discontinued Operations | ' | ||||||||
Pursuant to the Securities Exchange, the pre-existing mining business was discontinued. | |||||||||
On April 28, 2014 the Company notified Mexivada Mining Corp. and Compania Minera Mexivada S.A de C.V., of termination of the Mexivada Property Option Agreement dated as of February 11, 2011, as amended October 24, 2011, and that the Company would not pay any further fees or expenses associated with the Agreement. The remaining interests were sold on July 24, 2014. | |||||||||
The following table presents summarized operating results for these discontinued operations. The table below does not present MV Patents because the historical financial information represents the activity of MV Patents as the predecessor business to VRE, and does not include any of the operations of the discontinued exploration stage mining business. The historical financial information for MV Patents for the three months ended September 30, 2013 is included in the accompanying consolidated financial statements. | |||||||||
Three Months Ended September 30, 2014 | |||||||||
Loss from discontinued operations | $ | 441 | |||||||
Components of assets from discontinued operations consist of the following as of September 30, 2014 and June 30, 2014. | |||||||||
30-Sep-14 | 30-Jun-14 | ||||||||
Current assets: | |||||||||
Property and equipment | $ | 8,809 | $ | 8,809 | |||||
Less: accumulated depreciation | (5,642 | ) | (5,201 | ) | |||||
Total assets held for sale | $ | 3,167 | $ | 3,608 |
Related_Party_Transactions
Related Party Transactions | 3 Months Ended |
Sep. 30, 2014 | |
Related Party Transactions [Abstract] | ' |
Note 5 - Related Party Transactions | ' |
Officer and director fees totaled $148,250 and $86,524 for the three month periods ended September 30, 2014 and 2013, respectively. The total compensation of officers and directors was recorded as a component of general and administrative expenses. | |
In September 2014 the Company granted 4,690,339 common stock options to its officers (see Note 10). The total fair value of the award was estimated to be $9,380,675. Share-based compensation expense is recognized ratably over the vesting periods. For the three month period ended September 30, 2014, the Company recognized share-based compensation expense as a component of general and administrative expenses of $2,669,673. | |
As of September 30, 2014 and June 30, 2014, the Company owed its officers and directors $17,917 for compensation which was recorded as accounts payable and accrued liabilities in its consolidated balance sheets. | |
In August 2014, the Company issued 300,000 shares of common stock for certain unpatented mining claims valued at $450,000 on the date of the acquisition. The mining claims were owned by a company whose sole owner is an officer and Director of the Company. | |
Derivative_Liabilities
Derivative Liabilities | 3 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Notes to Financial Statements | ' | ||||||||
Note 6 - Derivative Liabilities | ' | ||||||||
As of September 30, 2014 and June 30, 2014, there were 2,823,128 and 2,820,778 outstanding derivative warrants, respectively, with 1,411,564 and 1,410,389 common shares issuable upon exercise, respectively. The warrants qualify as derivative liabilities due to the existence of reset provisions which cause the instruments to no longer be indexed to the Company’s own stock under FASB ASC 815. | |||||||||
The Company estimated the fair value of the outstanding derivative warrants using a probability-weighted scenario analysis model. As of September 30, 2014 and June 30, 2014, the fair value of the derivative warrants was determined to be $2,283,712 and $2,365,315, respectively resulting in a gain on the change in the fair value of derivative liabilities of $81,603 for the three month period ended September 30, 2014. | |||||||||
The following is a summary of the key assumptions used in the probability-weighted scenario analysis model to estimate the fair value of the warrants as of September 30, 2014 and June 30, 2014: | |||||||||
30-Sep-14 | 30-Jun-14 | ||||||||
Common stock issuable upon exercise of warrants | 1,411,564 | 1,410,389 | |||||||
Exercise price | $ | 1.1 | $0.90 and $1.10 | ||||||
Market price of the Company’s common stock | $ | 1.7 | $ | 1.75 | |||||
Risk free interest rate | 0.58 | % | 0.47 | % | |||||
Dividend yield | 0 | % | 0 | % | |||||
Volatility | 336.01 | % | 278.08 | % | |||||
Expected term | 1.23-1.79 years | 1.48-2.04 years | |||||||
See Note 7 for fair value hierarchy of the derivative liabilities. | |||||||||
Fair_Value_Measurements
Fair Value Measurements | 3 Months Ended | ||||||||||||
Sep. 30, 2014 | |||||||||||||
Fair Value Measurements | ' | ||||||||||||
Note 7 - Fair Value Measurements | ' | ||||||||||||
As defined in FASB ASC Topic 820, fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. This Topic requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. The statement requires fair value measurements be classified and disclosed in one of the following categories: | |||||||||||||
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis. | |||||||||||||
Level 2: Pricing inputs other than quoted market prices included in Level 1 that are based on observable market data and are directly or indirectly observable for substantially the full term of the asset or liability. These include quoted market prices for similar assets or liabilities, quoted market prices for identical or similar assets in markets that are not active, adjusted quoted market prices, inputs from observable data such as interest rate and yield curves, volatilities or default rates observable at commonly quoted intervals or inputs derived from observable market data by correlation or other means. | |||||||||||||
Level 3: Pricing inputs that are unobservable or less observable from objective sources. Unobservable inputs should only be used to the extent observable inputs are not available. These inputs maintain the concept of an exit price from the perspective of a market participant and should reflect assumptions of other market participants. An entity should consider all market participant assumptions that are available without unreasonable cost and effort. These are given the lowest priority and are generally used in internally developed methodologies to generate management's best estimate of the fair value when no observable market data is available. | |||||||||||||
Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. | |||||||||||||
The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels. Certain assets and liabilities are reported at fair value on a recurring or non-recurring basis in the Company’s consolidated balance sheets. The following methods and assumptions were used to estimate the fair values: | |||||||||||||
Cash, Prepaid expenses, Accounts payable, Accrued liabilities | |||||||||||||
The carrying amounts approximate fair value because of the short-term nature or maturity of the instruments. | |||||||||||||
Derivative liabilities | |||||||||||||
The Company’s determination of fair value of its derivative instruments incorporates various factors required under FASB Topic ASC 815. See Note 6 for the fair value calculations. The fair values of the Company’s derivatives are valued using less observable data from objective sources as inputs into internal valuation models. Therefore, the Company considers the fair value of its derivatives to be Level 3 hierarchy. | |||||||||||||
The following table sets forth the fair value hierarchy within our financial assets and liabilities by level that they were accounted for at fair value on a recurring basis as of September 30, 2014 and June 30, 2014: | |||||||||||||
Fair Value Measurement at September 30, 2014 | |||||||||||||
Level 1 | Level 2 | Level 3 | |||||||||||
Liabilities: | |||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 2,283,712 | |||||||
Total | $ | - | $ | - | $ | 2,283,712 | |||||||
Fair Value Measurement at June 30, 2014 | |||||||||||||
Level 1 | Level 2 | Level 3 | |||||||||||
Liabilities: | |||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 2,365,315 | |||||||
Total | $ | - | $ | - | $ | 2,365,315 | |||||||
The following table sets forth the changes in the fair value of derivative liabilities for the three month period ended September 30, 2014: | |||||||||||||
Balance, June 30, 2014 | $ | 2,365,315 | |||||||||||
Change in fair value of derivative liabilities | (81,603 | ) | |||||||||||
Balance, September 30, 2014 | $ | 2,283,712 |
Convertible_Notes
Convertible Notes | 3 Months Ended |
Sep. 30, 2014 | |
Debt Disclosure [Abstract] | ' |
Note 8 - Convertible Notes | ' |
On September 2, 2014, the Company converted $351,271 of convertible notes, including accrued interest of $26,271, into 3,512,710 shares of the Company’s Series B convertible preferred stock, par value $0.001 (the “Series B Preferred Stock”), at a post-Reverse Split conversion price of $0.10 and subject to a 9.99% conversion blocker. Each share of Series B Preferred Stock will participate in dividends and other distributions on an equivalent basis with common stock. Holders of Series B Preferred Stock shall vote together with the holders of common stock as a single class, and each holder of outstanding shares of Series B Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of common stock into which the shares of Series B Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on a particular matter. | |
On August 26, 2014, the Company converted $3,858,578 of convertible notes, including accrued interest of $198,583, into 7,717,170 shares of the Company’s Series C convertible preferred stock, par value $0.001 (the “Series C Preferred Stock”), at a post-Reverse Split conversion price of $0.50 and subject to a 9.99% conversion blocker. Each share of Series C Preferred Stock will be entitled to a liquidation preference equal to $0.001 per share. Otherwise, the Series C Preferred Stock will be equivalent in all respects to the Common Stock, with each share of Series C Preferred stock entitled to one vote and the holders of the Series C Preferred Stock voting together with the holders of the Common Stock. The Series C Preferred Stock is convertible into common stock at a ratio of 1 to 1. | |
Pursuant to the conversion of convertible notes into Series C Preferred Stock, the Company incurred interest expense of $3,660,000 related to a beneficial conversion feature that existed within the underlying transactions. | |
During the three month period ended September 30, 2014, additional amortization expense of $211,543 and $689,556 was recognized associated with the debt discounts and deferred financing costs, respectively, related to the notes originally issued in November 2013, February 2014 and March 2014. The discounts and deferred financing costs associated with these notes were completely amortized at September 30, 2014. |
Stockholders_Equity
Stockholders' Equity | 3 Months Ended |
Sep. 30, 2014 | |
Notes to Financial Statements | ' |
Note 9 - Stockholders' Equity | ' |
In August 2014, the Company issued 300,000 common shares for certain unpatented mining claims valued at $450,000 on the date of the acquisition. The mining claims were owned by a company whose sole owner is a related party. | |
In September 2014, the Company issued 79,530 shares of Series B Preferred Stock as settlement of an outstanding payable of $79,530 for legal fees owed to an unrelated party. The fair value of the shares was determined to be $300,000 resulting in an additional expense of $220,470 recognized during the three months ended September 30, 2014. All shares of Series B Preferred Stock are convertible into common stock at a ratio of 1 to 1. | |
In September 2014, the Company issued an aggregate of 1,400,000 common shares to unrelated parties in exchange for financial advisory, investment banking and consulting services valued at $2,800,000. The expense was recognized in full during the three months ended September 30, 2014. | |
In September 2014, the Company issued an aggregate of 169,505 common shares to two unrelated parties as settlement of outstanding payables of $109,159 owed for professional services. The fair value of the shares was determined to be $339,009 resulting in an additional expense of $229,850 recognized during the three months ended September 30, 2014. | |
In September 2014, the Company issued 20,000 shares of Series D convertible preferred stock (the “Series D Preferred Stock”), to officers and Directors for compensation valued at $40,000. The Series D Preferred Stock will be equivalent in all respects to the Company’s common stock, except that each share of Series D Preferred Stock will be entitled to cast 1,000 votes per share and contain liquidation preference. All shares of Series D Convertible Preferred Stock are convertible into common stock at a ratio of 1 to 1. | |
As a result of the effectuation of the Reverse Split on September 8, 2014, the Company issued 4,000,000 common shares under an exchange agreement for warrants originally issued in November 2013. | |
Outstanding shares of Series A convertible preferred stock are convertible into common shares at a ratio of 100 to 1. |
Stock_Options_and_Warrants
Stock Options and Warrants | 3 Months Ended | ||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||
Equity [Abstract] | ' | ||||||||||||||||
Note 10 - Stock Options and Warrants | ' | ||||||||||||||||
Options | |||||||||||||||||
On February 7, 2014, the Company’s Board of Directors voted to terminate the 2007 Stock Option Plan and adopted the 2014 Equity Incentive Plan (the “2014 Plan”), which provides for the issuance of incentive awards of up to 6,150,564 shares of the Company’s Common Stock to officers, key employees, consultants and directors. The options’ exercise price will be no less than the closing price of the Company’s shares on the day of issuance. When incentive stock options are granted to an employee who, at the time the incentive stock option is granted, owns stock representing more than 10% of the voting power of all classes of stock of the Company, the per share exercise price will be no less than 110% of the closing price of the Company’s shares on the day of issuance. | |||||||||||||||||
On February 7, 2014, the Company granted an aggregate of 4,690,339 common stock options to certain officers and advisors of the Company. The stock options were granted upon the effectuation of the Reverse Split on September 8, 2014. The options are exercisable at $0.50 per share and expire on February 7, 2024. 3,690,339 of the options vest in twelve quarterly installments beginning February 7, 2014 and 1,000,000 of the options vest in twelve monthly installments beginning February 7, 2014. The total fair value of the award was estimated to be $9,380,675. $2,669,673 was expensed during the three months ended September 30, 2014 and $6,711,002 will be recognized over the remaining vesting period of the options. These were the only stock options outstanding at September 30, 2014, leaving 1,460,225 options available for grant under the 2014 Plan. | |||||||||||||||||
The estimated fair value of each option award granted was determined on the date of effectiveness of the grant using the Black-Scholes option valuation model. The following weighted-average assumptions were used for the options granted during the three months ended September 30, 2014: | |||||||||||||||||
2014 | |||||||||||||||||
Risk-free interest rate | 2.48% | ||||||||||||||||
Expected volatility | 312.48% - 317.03% | ||||||||||||||||
Dividend yield | 0% | ||||||||||||||||
Expected option term | 10 years | ||||||||||||||||
A summary of the status of the Company’s stock option plan as of September 30, 2014 and changes during the three months ended September 30, 2014 is as follows: | |||||||||||||||||
Options | Weighted Average Exercise Price | Weighted Average Remaining Term (Years) | Aggregate Intrinsic Value | ||||||||||||||
Outstanding at June 30, 2014 | - | $ | - | ||||||||||||||
Granted | 4,690,339 | 0.5 | |||||||||||||||
Outstanding at September 30, 2014 | 4,690,339 | 0.5 | 9.362 | $ | 5,628,407 | ||||||||||||
Exercisable at September 30, 2014 | 1,198,390 | $ | 0.5 | 9.362 | $ | 1,438,068 | |||||||||||
Warrants | |||||||||||||||||
The following table presents the warrant activity during the three month period ended September 30, 2014 presented on a post 1 for 100 Reverse Split basis: | |||||||||||||||||
Common Shares Covered by Warrants | Weighted Average Exercise Price | Weighted Average Remaining Term (Years) | Aggregate Intrinsic Value | ||||||||||||||
Outstanding at June 30, 2014 | 2,000,689 | $ | 0.894 | 1.879 | $ | 1,860,154 | |||||||||||
Granted | - | - | |||||||||||||||
Reset adjustment | 1,175 | 1.1 | |||||||||||||||
Outstanding at September 30, 2014 | 2,001,864 | $ | 0.924 | 1.627 | $ | 1,555,298 | |||||||||||
Exercisable at September 30, 2014 | 2,006,955 | $ | 0.924 | 1.627 | $ | 1,555,298 |
Retirement_Plan
Retirement Plan | 3 Months Ended |
Sep. 30, 2014 | |
Compensation and Retirement Disclosure [Abstract] | ' |
Note 11 - Retirement Plan | ' |
Effective January 1, 2014, the Company adopted a qualified 401(k) deferred compensation plan, with deferrals beginning in June 2014. All employees who are eighteen years or older and have worked for at least three consecutive months are eligible to participate in the plan. The plan provides for mandatory safe-harbor matching contributions and discretionary non-elective contributions as determined by management. The Company did not elect to make any contributions for the three month period ended September 30, 2014. |
Commitments_and_Contingencies
Commitments and Contingencies | 3 Months Ended | ||||
Sep. 30, 2014 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Note 12 - Commitments and Contingencies | ' | ||||
Concentration of Credit Risk | |||||
The Company maintains its cash in a restricted escrow account in an institution insured by the Federal Deposit Insurance Corporation and, at times, balances may exceed government insured limits. The Company has never experienced any losses related to these balances. | |||||
Employment Agreements | |||||
The Company has employment agreements with two employees and a separate consulting agreement with one of the Company’s executive officers. The aggregate future commitment under these agreements is as follows: | |||||
Twelve Months ending September 30, | |||||
2015 | $ | 475,000 | |||
2016 | 430,000 | ||||
2017 | 150,500 | ||||
$ | 1,055,500 | ||||
These agreements provide for additional bonus payments that are calculated as defined. | |||||
Other | |||||
The Company is involved in various legal proceedings and litigation arising in the ordinary course of business. In the opinion of management and legal counsel, the outcome of such proceedings and litigation will not have a material adverse effect on the Company's consolidated financial statements. | |||||
Pursuant to the Securities Exchange the Company agreed to pay the members of MV Patents ten (10%) percent of the net proceeds to be received from any enforcement activities or sales transactions related to the patents owned or applications pending as of the closing of the Securities Exchange. | |||||
Outstanding shares of common stock includes 150,000 shares that contain nonstandard anti-dilution provisions which reset with future issuances of common stock if the Company issues any common stock, or securities convertible into or exercisable for shares of common stock, at a price per share or conversion or exercise price per share less than $2.00. These anti-dilution rights mature on December 31, 2015. | |||||
Subsequent_Events
Subsequent Events | 3 Months Ended |
Sep. 30, 2014 | |
Subsequent Events [Abstract] | ' |
Note 13 - Subsequent Events | ' |
In October 2014, the Company issued 1,221,250 common shares upon the conversion of 1,221,250 shares of Series B preferred stock. | |
In October 2014, the Company issued an aggregate of 2,685,555 common shares upon the conversion of 2,685,555 shares of Series C preferred stock. | |
In October 2014, the Company issued 400,000 common shares and warrants to purchase 900,000 common shares to a third party for consulting services. There are 3 tranches of warrants, each comprising of warrants to purchase 300,000 shares, at exercise prices of $0.50, $1,00 and $2.00 per share. The warrants are exercisable immediately and expire on October 27, 2019. | |
Discontinued_Operations_Tables
Discontinued Operations (Tables) | 3 Months Ended | ||||
Sep. 30, 2014 | |||||
Discontinued Operations and Disposal Groups [Abstract] | ' | ||||
Loss from discontinued operations and assets and liabilities acquired | ' | ||||
Three Months Ended September 30, 2014 | |||||
Loss from discontinued operations | $ | 441 |
Derivative_Liabilities_Tables
Derivative Liabilities (Tables) | 3 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Notes to Financial Statements | ' | ||||||||
Fair value assumptions | ' | ||||||||
30-Sep-14 | 30-Jun-14 | ||||||||
Common stock issuable upon exercise of warrants | 1,411,564 | 1,410,389 | |||||||
Exercise price | $ | 1.1 | $0.90 and $1.10 | ||||||
Market price of the Company’s common stock | $ | 1.7 | $ | 1.75 | |||||
Risk free interest rate | 0.58 | % | 0.47 | % | |||||
Dividend yield | 0 | % | 0 | % | |||||
Volatility | 336.01 | % | 278.08 | % | |||||
Expected term | 1.23-1.79 years | 1.48-2.04 years |
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 3 Months Ended | ||||||||||||
Sep. 30, 2014 | |||||||||||||
Fair Value Measurements Tables | ' | ||||||||||||
Company's Financial Assets and Liabilities Accounted at Fair Value on Recurring Basis | ' | ||||||||||||
Fair Value Measurement at September 30, 2014 | |||||||||||||
Level 1 | Level 2 | Level 3 | |||||||||||
Liabilities: | |||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 2,283,712 | |||||||
Total | $ | - | $ | - | $ | 2,283,712 | |||||||
Fair Value Measurement at June 30, 2014 | |||||||||||||
Level 1 | Level 2 | Level 3 | |||||||||||
Liabilities: | |||||||||||||
Warrant derivative liabilities | $ | - | $ | - | $ | 2,365,315 | |||||||
Total | $ | - | $ | - | $ | 2,365,315 | |||||||
Reconciliation of Changes in Fair Value of Assets and Liabilities Classified As Level 3 | ' | ||||||||||||
Balance, June 30, 2014 | $ | 2,365,315 | |||||||||||
Change in fair value of derivative liabilities | (81,603 | ) | |||||||||||
Balance, September 30, 2014 | $ | 2,283,712 | |||||||||||
Stock_Options_and_Warrants_Tab
Stock Options and Warrants (Tables) | 3 Months Ended | ||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||
Equity [Abstract] | ' | ||||||||||||||||
Option fair value assumptions | ' | ||||||||||||||||
2014 | |||||||||||||||||
Risk-free interest rate | 2.48% | ||||||||||||||||
Expected volatility | 312.48% - 317.03% | ||||||||||||||||
Dividend yield | 0% | ||||||||||||||||
Expected option term | 10 years | ||||||||||||||||
Option activity | ' | ||||||||||||||||
Options | Weighted Average Exercise Price | Weighted Average Remaining Term (Years) | Aggregate Intrinsic Value | ||||||||||||||
Outstanding at June 30, 2014 | - | $ | - | ||||||||||||||
Granted | 4,690,339 | 0.5 | |||||||||||||||
Outstanding at September 30, 2014 | 4,690,339 | 0.5 | 9.362 | $ | 5,628,407 | ||||||||||||
Exercisable at September 30, 2014 | 1,198,390 | $ | 0.5 | 9.362 | $ | 1,438,068 | |||||||||||
Warrant activity | ' | ||||||||||||||||
Common Shares Covered by Warrants | Weighted Average Exercise Price | Weighted Average Remaining Term (Years) | Aggregate Intrinsic Value | ||||||||||||||
Outstanding at June 30, 2014 | 2,000,689 | $ | 0.894 | 1.879 | $ | 1,860,154 | |||||||||||
Granted | - | - | |||||||||||||||
Reset adjustment | 1,175 | 1.1 | |||||||||||||||
Outstanding at September 30, 2014 | 2,001,864 | $ | 0.924 | 1.627 | $ | 1,555,298 | |||||||||||
Exercisable at September 30, 2014 | 2,006,955 | $ | 0.924 | 1.627 | $ | 1,555,298 |
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 3 Months Ended | ||||
Sep. 30, 2014 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Aggregate future commitment under employment agreements | ' | ||||
Twelve Months ending September 30, | |||||
2015 | $ | 475,000 | |||
2016 | 430,000 | ||||
2017 | 150,500 | ||||
$ | 1,055,500 | ||||
General_Organization_and_Busin1
General Organization and Business (Details Narrative) (USD $) | 3 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Sale of shares for reverse merger, value per share | $0.10 |
Reverse stock split | '1 for 100 |
Discontinued_Operations_Detail
Discontinued Operations (Details) (USD $) | 3 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | |
Discontinued Operations and Disposal Groups [Abstract] | ' | ' | ' |
Loss from discontinued operations | ($441) | ' | ' |
Current assets: | 724,337 | ' | 2,442,445 |
Property and equipment, net | 8,809 | ' | 8,809 |
Less: accumulated depreciation | -5,642 | ' | -5,201 |
Total assets held for sale | $3,167 | ' | $3,608 |
Related_Party_Transactions_Det
Related Party Transactions (Details Narrative) (USD $) | 3 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | |
Officer and director fees | $148,250 | $86,524 | ' |
Accrued Salaries | 17,917 | ' | 17,917 |
Options granted to officers | 4,690,339 | ' | ' |
Share-based compensation expense, as component of G&A expense | 2,669,673 | ' | ' |
Officers [Member] | ' | ' | ' |
Options granted to officers | 4,690,339 | ' | ' |
Fair value of shares granted | 9,380,675 | ' | ' |
Share-based compensation expense, as component of G&A expense | 2,669,673 | ' | ' |
Mining Claims Related Party [Member] | ' | ' | ' |
Fair value of shares granted | $450,000 | ' | ' |
Common stock issued to related party for mining rights, shares | 300,000 | ' | ' |
Derivative_Liabilities_Details
Derivative Liabilities (Details) (USD $) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2014 | Jun. 30, 2014 | |
Common stock issuable upon exercise of warrants | 1,411,564 | 1,410,389 |
Exercise price | $1.10 | ' |
Market price of the Company's common stock | $1.70 | $1.75 |
Risk free interest rate | 0.58% | 0.47% |
Dividend yield | 0.00% | 0.00% |
Volatility | 336.01% | 278.08% |
MinimumMember | ' | ' |
Exercise price | ' | $0.90 |
Expected term | '1 year 2 months 23 days | '1 year 5 months 23 days |
MaximumMember | ' | ' |
Exercise price | ' | $1.10 |
Expected term | '1 year 9 months 14 days | '2 years 0 months 15 days |
Derivative_Liabilities_Details1
Derivative Liabilities (Details Narrative) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Jun. 30, 2014 | |
Notes to Financial Statements | ' | ' |
Warrants outstanding, derivative liabilities | 2,823,128 | 2,820,778 |
Common shares issuable upon exercise, derivative warrants | 1,411,564 | 1,410,389 |
Fair value of warrants outstanding | $2,283,712 | $2,365,315 |
Loss on change in fair value of derivative liabilities | ($81,603) | ' |
Fair_Value_Measurements_Detail
Fair Value Measurements (Details) (USD $) | Sep. 30, 2014 | Jun. 30, 2014 | ||
Derivative liability | $2,283,712 | [1] | $2,365,315 | [2] |
Fair Value, Inputs, Level 1 [Member] | ' | ' | ||
Derivative liability | ' | 2,365,315 | ||
Fair Value, Inputs, Level 2 [Member] | ' | ' | ||
Derivative liability | ' | ' | ||
Fair Value, Inputs, Level 3 [Member] | ' | ' | ||
Derivative liability | $2,283,712 | ' | ||
[1] | MV Portfolios, Inc. and Subsidiaries | |||
[2] | MV Patents, LLC |
Fair_Value_Measurements_Detail1
Fair Value Measurements (Details 1) (USD $) | 3 Months Ended |
Sep. 30, 2014 | |
Fair Value Measurements Details 1 | ' |
Derivative liabilities - beginning balance | $2,365,315 |
Change in fair value | -81,603 |
Derivative liabilities - ending balance | $2,365,315 |
Convertible_Notes_Details_Narr
Convertible Notes (Details Narrative) (USD $) | 3 Months Ended | |
Sep. 30, 2014 | Jun. 30, 2014 | |
Preferred stock, par value | $0.00 | $0.00 |
pre-Reverse Split conversion price | $0.50 | ' |
Amortization expense, debt discount | $211,543 | ' |
Amortization expense, deferred financing costs | 689,556 | ' |
ConvertibleNotesPayableMember | ' | ' |
Convertible note converted to Preferred Stock | 3,512,710 | ' |
Accrued interest | 26,271 | ' |
Preferred stock issued | 3,512,710 | ' |
Beneficial conversion interest expense | 3,660,000 | ' |
Preferred stock, par value | $0.00 | ' |
Conversion blocker | 99.90% | ' |
pre-Reverse Split conversion price | $0.10 | ' |
Convertible Notes Payable 2 [Member] | ' | ' |
Convertible note converted to Preferred Stock | 3,858,578 | ' |
Accrued interest | 198,583 | ' |
Preferred stock issued | 7,717,170 | ' |
Preferred stock, par value | $0.00 | ' |
Conversion blocker | 99.90% | ' |
pre-Reverse Split conversion price | $0.50 | ' |
Agent Fees [Member] | ' | ' |
Amortization expense, debt discount | $726,564 | ' |
Stockholders_Equity_Details_Na
Stockholders' Equity (Details Narrative) (USD $) | 3 Months Ended |
Sep. 30, 2014 | |
Share issuance expense | $2,669,673 |
Equity Issuance 1 [Member] | ' |
Issuance date | 1-Aug-14 |
Common stock issued | 300,000 |
Stock issued, value | 450,000 |
Equity Issuance 2 [Member] | ' |
Issuance date | 1-Sep-14 |
Preferred stock issued | 79,530 |
Stock issued, value | 300,000 |
Repayment of debt with share issuance | 79,530 |
Share issuance expense | 220,470 |
Equity Issuance 3 [Member] | ' |
Issuance date | 1-Sep-14 |
Common stock issued | 140,000 |
Stock issued, value | 2,800,000 |
Equity Issuance 4 [Member] | ' |
Issuance date | 1-Sep-14 |
Common stock issued | 169,505 |
Preferred stock issued | 339,009 |
Repayment of debt with share issuance | 109,159 |
Share issuance expense | 229,850 |
Equity Issuance 5 [Member] | ' |
Issuance date | 1-Sep-14 |
Preferred stock issued | 20,000 |
Stock issued, value | $40,000 |
Equity Issuance 6 [Member] | ' |
Issuance date | 1-Sep-14 |
Common stock issued | 4,000,000 |
Stock_Options_and_Warrants_Det
Stock Options and Warrants (Details) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2014 | Jun. 30, 2014 | |
Risk-free interest rate | 0.58% | 0.47% |
Expected volatility | 336.01% | 278.08% |
Dividend yield | 0.00% | 0.00% |
MinimumMember | ' | ' |
Expected option term | '1 year 2 months 23 days | '1 year 5 months 23 days |
MaximumMember | ' | ' |
Expected option term | '1 year 9 months 14 days | '2 years 0 months 15 days |
Options [Member] | ' | ' |
Risk-free interest rate | 2.48% | ' |
Dividend yield | ' | ' |
Expected option term | '10 years | ' |
Options [Member] | MinimumMember | ' | ' |
Expected volatility | 312.48% | ' |
Options [Member] | MaximumMember | ' | ' |
Expected volatility | 301.70% | ' |
Stock_Options_and_Warrants_Det1
Stock Options and Warrants (Details 1) (USD $) | 3 Months Ended |
Sep. 30, 2014 | |
Options | ' |
Granted | 4,690,339 |
Weighted Average Exercise Price | ' |
Granted | $0.50 |
Options [Member] | ' |
Options | ' |
Outstanding at beginning of period | ' |
Granted | 4,690,339 |
Outstanding at end of period | 46,903,399 |
Exercisable at end of period | 1,198,390 |
Weighted Average Exercise Price | ' |
Outstanding at beginning of period | ' |
Granted | $0.50 |
Outstanding at end of period | $0.50 |
Exercisable at end of period | 0.5 |
Weighted Average Remaining Term (Years) | ' |
Outstanding at end of period | '9 years 4 months 10 days |
Exercisable at end of period | '9 years 4 months 10 days |
Aggregate Intrinsic Value | ' |
Outstanding at end of period | $5,628,407 |
Exercisable at end of period | 1,438,068 |
Stock_Options_and_Warrants_Det2
Stock Options and Warrants (Details 2) (USD $) | 3 Months Ended |
Sep. 30, 2014 | |
Warrants | ' |
Granted | 4,690,339 |
Weighted Average Exercise Price | ' |
Granted | $0.50 |
Warrant | ' |
Warrants | ' |
Outstanding at beginning of period | 2,000,689 |
Granted | ' |
Reset adjustment | 1,175 |
Outstanding at end of period | 2,001,864 |
Exercisable at end of period | 2,006,955 |
Weighted Average Exercise Price | ' |
Outstanding at beginning of period | $0.89 |
Granted | ' |
Reset adjustment | $1.10 |
Outstanding at end of period | $0.92 |
Exercisable at end of period | 0.924 |
Weighted Average Remaining Term (Years) | ' |
Outstanding at beginning of period | '1 year 10 months 16 days |
Outstanding at end of period | '1 year 10 months 17 days |
Exercisable at end of period | '1 year 10 months 17 days |
Aggregate Intrinsic Value | ' |
At beginning of period | $1,860,154 |
Outstanding at end of period | $1,555,298 |
Exercisable at end of period | 1,555,298 |
Stock_Options_and_Warrants_Det3
Stock Options and Warrants (Details Narrative) (USD $) | 3 Months Ended |
Sep. 30, 2014 | |
Equity [Abstract] | ' |
Shares authorized for issuance under equity plan | 6,150,564 |
Granted, options | 4,690,339 |
Granted, exercise price | $0.50 |
Fair value of options granted | $9,380,675 |
Option issuance expense | $2,669,673 |
Options available for grant under plan | 1,460,225 |
Income_Taxes_Details
Income Taxes (Details) (USD $) | Sep. 30, 2014 | Jun. 30, 2014 |
Income Taxes Details | ' | ' |
Net operating loss carry-forwards | $801,000 | ' |
Valuation allowance | -801,000 | ' |
Net deferred tax asset | ' | ' |
Income_Taxes_Details_Narrative
Income Taxes (Details Narrative) (USD $) | Sep. 30, 2014 |
Income Taxes Details Narrative | ' |
Net operating loss carry-forwards for income taxes | $2,290,000 |
Commitments_and_Contingencies_1
Commitments and Contingencies (Details) (USD $) | Sep. 30, 2014 |
Commitments and Contingencies Disclosure [Abstract] | ' |
2015 | $475,000 |
2016 | 430,000 |
2017 | 150,500 |
Employment agreement commitment | $1,055,500 |
Commitments_and_Contingencies_2
Commitments and Contingencies (Details Narrative) | 3 Months Ended |
Sep. 30, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Commission rate to MV Patents | 10.00% |
Share subject to anti-dilution provisions | 150,000 |
Subsequent_Events_Details_Narr
Subsequent Events (Details Narrative) (USD $) | 1 Months Ended |
Nov. 14, 2014 | |
Shares issued for consulting services | 900,000 |
Warrant 1 [Member] | ' |
Shares issued for consulting services | 300,000 |
Shares issued for consulting services, price per warrant | 0.5 |
Warrant expiration date | 27-Oct-19 |
Warrant 2 [Member] | ' |
Shares issued for consulting services | 300,000 |
Shares issued for consulting services, price per warrant | 1 |
Warrant expiration date | 27-Oct-19 |
Warrant 3 [Member] | ' |
Shares issued for consulting services | 300,000 |
Shares issued for consulting services, price per warrant | 2 |
Warrant expiration date | 27-Oct-19 |
Series B Preferred Stock [Member] | ' |
Convertible shares converted to common stock | 1,221,250 |
Conversion of Preferred stock to common stock, Shares | 1,221,250 |
Series C Preferred Stock [Member] | ' |
Convertible shares converted to common stock | 2,685,555 |
Conversion of Preferred stock to common stock, Shares | 2,685,555 |